Researchers are getting closer to understanding the long-term impact of Mycoplasma genitalium, the often asymptomatic sexually transmitted infection that bears some resemblance to other well-known STIs like gonorrhea and chlamydia. Understanding the impact of this emerging pathogen is key to determining whether screening is needed and to informing treatment recommendations.